United States
Home Healthcare Life Sciences Life Sciences
Who We Are

With unique experience under our life sciences umbrella, we are a trusted, single-source partner supporting therapeutics from discovery to commercialization to tackle devastating diseases and improve patient lives. We provide our customers the innovation, speed, and scalability needed across every stage of the therapeutics journey to provide medicines to the millions of patients lacking sufficient treatment options.

Our Aspiration

To be the leading and most trusted Partners for Life, committed to building enduring relationships that span the entire drug development life cycle. ​

Partners for Life
Building trust through our Partners for Life Strategy
icon of people holding up a business
Put Our People First
icon of a factory and a computer chip
Transformative Science and Innovation
icon of a factory and packages delivered
Unprecedented Delivery
CDMO Services

Our end-to-end CDMO services are designed to support the development of biopharmaceuticals from preclinical to commercial launch.

Life Science Solutions

As trusted Partners for Life, ​we bring those discoveries to life with the raw materials, cell culture solutions, and services to support the manufacturing ​of biologics and vaccines.​

Global Footprint

We offer a centralized supply chain that ​serves all major markets worldwide, with facilities in the United States, Europe, and Japan. Regardless of our partners’ locations or their geopolitical concerns, we have the capabilities and reach to serve their needs.

Decades of Innovation and Technology Advancements
Our Core Identity of Innovation
  • AI x Digital Transformation​
  • Imaging and Sensing technology​
  • Quality management and excellence in precision manufacturing
Our Core Capabilities
  • Bio Science & Engineering Laboratory (Japan and US)​
  • State-of-the-art analytical and process sciences labs​
  • Process and Development scientists in each Life Science company
Bio AI Vision

Combining biomechanics and machine learning, ​we are developing AI-powered capabilities to predict production outcomes based on the culture conditions. ​

By leveraging proprietary imaging technology, sensing technologies, and AI experts cultivated in our imaging and ​ medical businesses as “ready-to-work” teams, we aim to ​raise the consistency and predictability of bioproduction. ​

Our simulations will reduce development time and improve antibody yields during the development stage, optimizing ​ media components and conditions for cell culture and other bioprocesses. ​

During production, this technology helps minimize variation ​ in quality and yield from batch-to-batch and site-to-site, facilitating smooth product transfer between sites.​

KojoX

Dual sourcing with modular facilities

We are transforming the industry through standardization of proven technologies and ways of working. We call this our kojoX philosophy. By applying a kojoX mindset we harmonize facility designs, equipment, processes, and procedures across our network to increase speed and at the same time ensure consistency, quality and scalability in biomanufacturing. This standardization allows us to replicate successful manufacturing capabilities at multiple sites and ensures uniform production methods, regardless of location. The result is that medicines are produced faster with the same high level of quality, reliability, and efficiency at every facility. 

Kojo — has a dual meaning in Japanese: "factory" and "improvement."

X — represents both the power of being location-agnostic and the exponential impact we seek to transform the industry.​

KojoX is supported by three pillars:

  1. Resilience: Standardized processes across locations. Geographic diversity of supply. 
  2. Scalability (Modular design): Rapid facility expansion. Efficient scale-up & scale-down. 
  3. Speed (Improve time-to-patient): Reduce tech-transfer time. Faster regulatory processes. 
OSZAR »